本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ADC Therapeutics SA

4.07
0.0000
成交量:42.10萬
成交額:170.21萬
市值:4.56億
市盈率:-2.58
高:4.11
開:4.06
低:3.98
收:4.07
52周最高:4.74
52周最低:1.05
股本:1.12億
流通股本:9,224.08萬
量比:0.47
換手率:0.46%
股息:- -
股息率:- -
每股收益(TTM):-1.5758
每股收益(LYR):-1.6246
淨資產收益率:-705.53%
總資產收益率:-22.99%
市淨率:-2.29
市盈率(LYR):-2.51

資料載入中...

2020/10/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/09/14

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/05/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/14

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/12

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/12

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/11

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/04/28

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/04/24

招股説明書

F-1 - Registration statement for certain foreign private issuers
2019/10/03

SEC問詢函

CORRESP [Cover] - Correspondence
2019/09/30

SEC問詢函

CORRESP [Cover] - Correspondence
2019/09/30

SEC問詢函

CORRESP [Cover] - Correspondence
2019/09/23

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2019/09/09

SEC問詢函

CORRESP [Cover] - Correspondence